Scarica l'app Stockscreener
69.65
0.78%
0.54
Pre-mercato:
70.01
0.36
+0.52%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALC Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$69.11
Aprire:
$69
Volume 24 ore:
3.14M
Relative Volume:
1.44
Capitalizzazione di mercato:
$33.97B
Reddito:
$10.63B
Utile/perdita netta:
$819.00M
Rapporto P/E:
42.02
EPS:
1.6577
Flusso di cassa netto:
$1.59B
1 W Prestazione:
+3.41%
1M Prestazione:
+3.02%
6M Prestazione:
-14.17%
1 anno Prestazione:
-23.83%
Intervallo 1D:
$68.86
$70.01
Intervallo di 1 settimana:
$66.17
$70.01
Portata 52W:
$61.84
$90.91
Alcon Inc Stock (ALC) Company Profile
Nome
Alcon Inc
Settore
Industria
Telefono
-
Indirizzo
-
Compare ALC vs ISRG, BDX, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
69.65 | 32.81B | 10.63B | 819.00M | 1.59B | 1.6577 |
ISRG
Intuitive Surgical Inc
|
353.10 | 127.84B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
168.40 | 43.79B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
40.08 | 33.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
214.29 | 29.46B | 5.54B | 1.52B | 1.74B | 10.37 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-26 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2026-01-30 | Iniziato | William Blair | Mkt Perform |
| 2026-01-20 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2026-01-09 | Downgrade | Stifel | Buy → Hold |
| 2025-12-11 | Downgrade | BofA Securities | Buy → Underperform |
| 2025-08-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-05-20 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-05-14 | Reiterato | BTIG Research | Buy |
| 2025-03-28 | Reiterato | Needham | Buy |
| 2025-03-25 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-01-24 | Reiterato | Needham | Buy |
| 2025-01-10 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | Reiterato | Needham | Buy |
| 2024-11-12 | Reiterato | Needham | Buy |
| 2024-10-10 | Aggiornamento | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2024-04-10 | Iniziato | Goldman | Buy |
| 2024-03-14 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | Ripresa | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | Iniziato | Bernstein | Outperform |
| 2023-12-18 | Downgrade | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | Iniziato | Stifel | Buy |
| 2023-12-04 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-05-10 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | Aggiornamento | Societe Generale | Sell → Hold |
| 2022-12-22 | Iniziato | Mizuho | Buy |
| 2022-11-17 | Downgrade | Societe Generale | Hold → Sell |
| 2022-08-11 | Downgrade | Societe Generale | Buy → Hold |
| 2022-05-13 | Ripresa | Credit Suisse | Outperform |
| 2022-05-12 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | Iniziato | Needham | Buy |
| 2022-03-11 | Iniziato | BofA Securities | Buy |
| 2022-01-18 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Iniziato | Oppenheimer | Perform |
| 2021-07-14 | Iniziato | Deutsche Bank | Buy |
| 2021-05-06 | Aggiornamento | Citigroup | Sell → Neutral |
| 2021-03-22 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-11-12 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-07-06 | Downgrade | Citigroup | Neutral → Sell |
| 2020-07-06 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-04-08 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Aggiornamento | Argus | Hold → Buy |
| 2020-03-24 | Aggiornamento | Societe Generale | Sell → Hold |
| 2020-03-13 | Aggiornamento | UBS | Neutral → Buy |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-26 | Aggiornamento | Berenberg | Hold → Buy |
| 2020-01-08 | Iniziato | Argus | Hold |
| 2019-10-29 | Iniziato | Stephens | Equal-Weight |
| 2019-08-21 | Reiterato | BofA/Merrill | Neutral |
| 2019-06-24 | Iniziato | SVB Leerink | Mkt Perform |
| 2019-06-14 | Iniziato | BTIG Research | Neutral |
| 2019-05-10 | Iniziato | Robert W. Baird | Outperform |
| 2019-05-02 | Iniziato | Credit Suisse | Outperform |
Mostra tutto
Alcon Inc Borsa (ALC) Ultime notizie
Alcon stock trades steadily as surgical vision business underpins earnings growth - Ad-hoc-news.de
Alcon stock trades steadily as eye-care leader builds on profitable growth and margins - Ad-hoc-news.de
Alcon stock trades steadily as ophthalmic specialist reports higher 2024 revenue and margin improvem - Ad-hoc-news.de
Systane Ultra by Alcon Incdry eye relief anchored in a broad product line - Ad-hoc-news.de
Alcon stock trades steadily as ophthalmic leader focuses on growth and margins - Ad-hoc-news.de
Alcon Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh Revenue Breakdown – BMFBOVESPA:A2LC34 - TradingView
Alcon stock holds as 2025 revenue and margin growth guide the story - Ad-hoc-news.de
Alcon stock trades steadily as eye-care leader posts higher 2024 revenue and margins - Ad-hoc-news.de
Alcon stock trades steadily as earnings and eye care demand support valuation - Ad-hoc-news.de
Alcon stock holds steady as investors await fresh catalyst - AD HOC NEWS
Alcon | 7/24/26 - ktnv.com
Alcon gets you seeing in time for school - WSBT
Alcon: Back-to-School eye exams. What every parent should know. - KHGI
Alcon (ALC) Unveils Advanced Training Center for Vitreoretinal S - GuruFocus
Aravind Eye Care System and Alcon Launch Global Centre of Excellence for Retina Training in Coimbatore, India - PR Newswire
Alcon stock trades steady as eye care specialist builds on 2025 growth and higher margins - Ad-hoc-news.de
Systane Complete by Alcon Inc.dry eye relief built on oil-based drops - AD HOC NEWS
ALC|Alcon AG|Price:67.270|Chg%:-0.640 - TradingKey
Alcon stock trades steadily as surgical eye care revenue grows - AD HOC NEWS
ALC stock trades steadily as Alcon lifts 2024 outlook on stronger surgical and vision care demand - Ad-hoc-news.de
Enterprise value to revenue forward of Alcon AG – SIX:ALC - TradingView
Alcon stock trades steadily as recent earnings highlight margin and growth mix - Ad-hoc-news.de
Alcon (SWX:ALC) Stock Looks Undervalued On Cash Flow But Fair On Earnings - Yahoo Finance
Alcon stock supported by steady growth and surgical demand - Ad-hoc-news.de
A Look at Alcon Inc (ALC) After 3.8% Decline -- GF Value $91.41 vs Price $67.35 - GuruFocus
ALC|Alcon AG|Price:67.210| - TradingKey
Alcon stock holds its ground as 2025 sales and profit metrics frame the 22 July 2026 setup - Ad-hoc-news.de
Sight Sciences wins $34M patent ruling against Alcon - MSN
The Systane Ultra Lubricant Eye Drops. Dry-eye care with a long shelf presence - Ad-hoc-news.de
Alcon stock trades steady as recent earnings highlight margin and growth dynamics - Ad-hoc-news.de
Alcon stock trades steadily as eye-care leader posts rising revenue and margins - Ad-hoc-news.de
Alcon stock steadies as surgical eye-care demand supports revenue growth - Ad-hoc-news.de
Alcon stock trades steadily as surgical vision business supports earnings - Ad-hoc-news.de
Alcon stock trades steadily as surgical eye-care growth supports earnings - Ad-hoc-news.de
Mexican Gold Mining Corp. and Alcon Silver Corp. Complete Arrangement to Create Platauro Metals Corp., a Diversified Precious Metals Exploration Company - TMX Newsfile
Alcon Inc. (ALC) Stock Analysis: Navigating 24.66% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Alcon stock trades steadily as surgical eye care growth supports earnings outlook - Ad-hoc-news.de
Price to book forward of Alcon AG – BX:2U3 - TradingView
Alcon stock trades steadily as eye-care demand supports revenue growth - Ad-hoc-news.de
Alcon stock trades near recent highs as surgical vision demand supports growth - Ad-hoc-news.de
Alcon stock trades steadily as eye care group highlights Q1 2026 growth and margins - Ad-hoc-news.de
Alcon stock trades steadily as eye care leader builds on solid revenue growth - Ad-hoc-news.de
Alcon stock steadies as investors weigh surgical vision growth and recent earnings trends - Ad-hoc-news.de
Alcon stock trades steady as eye-care margins support growth outlook - Ad-hoc-news.de
Alcon stock trades steadily as surgical eye care growth supports margins - ad-hoc-news.de
Systane Augentropfen by Alcon Inc.dry-eye relief built on medical data - ad-hoc-news.de
Alcon stock trades steady as vision care group focuses on margin and growth after 2025 earnings - Ad-hoc-news.de
Alcon stock trades steadily as surgical eye care growth supports recent earnings - ad-hoc-news.de
Alcon stock trades steady as latest earnings show margin resilience - ad-hoc-news.de
Mizuho Securities Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $80 - Moomoo
Alcon stock holds steady as eye-care demand supports the long-term growth story - ad-hoc-news.de
Alcon Inc Azioni (ALC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.06%
2.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):